Changes in visceral fat begin around week 2: patients typically notice abdominal changes starting 2 weeks in, with more significant results by months 2 and 3
Because the symptoms are often non-specific, they are easy to attribute to other causes
Subcutaneous injection depth targets the fat layer under skin but above muscle
Key characteristics: A short fragment (approximately 1517 amino acids depending on the exact modification) rather than a full-length hormone Referenced in literature exploring structure-activity relationships within specific growth hormone fragments Distinct in origin and mechanism of interest from full-length growth hormone or GHRH analogues such as tesamorelin Structural Comparison Table Why Researchers Distinguish Between Them Despite both being short peptides sometimes discussed in metabolic research contexts, MOTS-C and AOD9604 have entirely different biological origins and mechanisms of research interest
This makes injections highly effective for pernicious anaemia and other malabsorption syndromes, including post-gastrectomy states, Crohn's disease affecting the terminal ileum, and certain medications that interfere with B12 uptake
Before receiving folic acid or methylcobalamin, patients should be assessed for deficiency and appropriate therapy started concurrently
